Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,606.49
(
-0.27%
)
US TECH 100
23,784.00
(
-0.05%
)
Dow Jones
46,021.43
(
-0.44%
)
Brent Oil
104.43
(
-2.02%
)
Bitcoin
70,035.79
(
-1.69%
)
News Focus
News Focus
Post# of 257262
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 122802
Boards Moderated 10
Alias Born 09/05/2002

DewDiligence

Member Level

Re: Biopharm investor post# 13006

Thursday, 07/07/2005 9:51:14 PM

Thursday, July 07, 2005 9:51:14 PM

Post# of 257262
Re: One better

>>That's nothing! Longs on the GNTA board were absolutely convinced Genasense would surpass Lipitor to become the best selling prescription medication in the history of healthcare with annual sales of $9.5 billion --- and that was just in the first 8 lead cancer indications alone! PPS predictons were, as I recall, in the $2500/share territory.<<

Wasn’t there an even more outlandish post where someone claimed Aventis sold Camptosar to PFE in order to free up Aventis’ oncology salesforce to focus exclusively on Genasense!!?

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Trade Smarter with Thousands

Leverage decades of market experience shared openly.

Join Now